Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Alzheimer Patients”

Showing 7 of 0 results

Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Post-approval studies (Phase 4)Study completedNCT02097056
What this trial is testing

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 171
Large-scale testing (Phase 3)Not Yet RecruitingNCT05303701
What this trial is testing

GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD)

Who this might be right for
Moderate to Severe Alzheimer's Disease
Samsung Pharmaceutical Co., Ltd. 750
Not applicableStudy completedNCT01796314
What this trial is testing

Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 170
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Study completedNCT00566501
What this trial is testing

Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 915
Large-scale testing (Phase 3)Ended earlyNCT00912288
What this trial is testing

Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 86

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation